We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,576 results
  1. Ticlopidine

    Reference work entry 2024
  2. Plasma/ticlopidine

    Article 18 February 2023
  3. Ticlopidine

    Article 10 April 2021
  4. Ticlopidine

    Article 22 February 2020
  5. Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy

    This study aimed to assess the effects of thienopyridine-class antiplatelet agents (including ticlopidine, clopidogrel, and prasugrel) on bleeding...

    Masashi Kubota, Mutsushi Kawakita, ... Takayuki Goto in Scientific Reports
    Article Open access 11 March 2024
  6. Prediction of Drug–Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model

    Background and Objective

    A physiologically based pharmacokinetic (PBPK) modeling approach for esketamine and its metabolite noresketamine after...

    Marie-Emilie Willemin, Peter Zannikos, ... Jan Snoeys in Clinical Pharmacokinetics
    Article 17 May 2022
  7. Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions

    About 1–10% of all serious adverse drug reactionsSerious adverse drug reactions (sADRs) are reported to the Food and Drug Administration (FDA) (...
    Matthew A. Taylor, Ashley C. Godwin, ... Charles L. Bennett in Cancer Drug Safety and Public Health Policy
    Chapter 2022
  8. Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis

    Purpose

    To comprehensively compare the efficacy of different antiplatelet therapies for secondary prevention of lacunar stroke (LS).

    Methods ...
    **aowen Hou, Kaiwen Cen, ... Xu Feng in European Journal of Clinical Pharmacology
    Article 07 November 2022
  9. Induction of clastogenesis and gene mutations by carbamazepine (at its therapeutically effective serum levels) in mammalian cells and the dependence on human CYP2B6 enzyme activity

    Carbamazepine (CBZ, an antiepileptic) is metabolized by multiple CYP enzymes to its epoxide and hydroxides; however, whether it is genotoxic remains...

    Yujian Wang, Yuting Chen, ... Yungang Liu in Archives of Toxicology
    Article 30 March 2023
  10. Aspirin/ticlopidine

    Article 10 August 2019
  11. Ticlopidine

    Article 13 July 2019
  12. Ticlopidine

    Article 06 July 2019
  13. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis

    Background

    Antiplatelet drugs may prevent recurrent ischemic events after ischemic stroke but their relative effectiveness and harms still need to be...

    Cinzia Del Giovane, Giorgio B. Boncoraglio, ... Irene Tramacere in BMC Neurology
    Article Open access 16 August 2021
  14. Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy

    Background

    We investigated whether antiplatelet/anticoagulant (APAC) therapy can protect patients with type 2 diabetes mellitus (T2DM) from the...

    Chi-Juei Jeng, Yi-Ting Hsieh, ... I-Jong Wang in BMC Ophthalmology
    Article Open access 17 March 2022
  15. Antithrombotic Therapy for Heterogeneous Causes of Stroke

    Ischemic stroke is a leading cause of death and a primary cause of long-term disability. Patients surviving the initial event are at a high risk of...
    Atul Ashok Kalanuria, Melanie Walker, Geoffrey Ling in Ischemic Stroke Therapeutics
    Chapter 2024
  16. Warfarin/ticlopidine

    Article 01 December 2018
  17. Multiple drugs

    Article 24 February 2024
  18. Abciximab

    Article 24 June 2023
Did you find what you were looking for? Share feedback.